Narsoplimab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
New Anticomplement Drugs in Nephrology - Mechanism and Indication.
Journal: Kidney & blood pressure research
Published: November 28, 2025
Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care.
Journal: Blood advances
Published: June 23, 2025
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA).
Journal: American journal of hematology
Published: May 30, 2025
Targeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System.
Journal: Medicina (Kaunas, Lithuania)
Published: March 24, 2025
Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).
Journal: Bone marrow transplantation
Published: January 17, 2025
Translating biomarker insights into practice: a path forward in TA-TMA management.
Journal: Frontiers in medicine
Published: December 23, 2024
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
Journal: Bone marrow transplantation
Published: February 27, 2024
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Journal: Transplantation and cellular therapy
Published: November 18, 2023
Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus.
Journal: Bone marrow transplantation
Published: October 24, 2023
Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders.
Journal: Frontiers in immunology
Published: September 19, 2023
Advances in the treatment of IgA nephropathy with biological agents.
Journal: Chronic diseases and translational medicine
Published: September 17, 2023
Last Updated: 04/28/2026